Global News Distribution

Medical

Touring Health Launches Mobile Medical Care Service For The Entertainment Industry

February 7, 2024 (Global News Distribution) -

Touring Health; the leading concierge medical and wellness service is hitting the road, paving the way for people working in the entertainment industry to receive expert medical treatments and consultations within the comfort of their home or tour locations.

Touring Health; the leading concierge medical and wellness service is hitting the road, paving the way for people working in the entertainment industry to receive expert medical treatments and consultations within the comfort of their home or tour locations. Through a staff of Emergency Room-trained nurses and doctors around the world, they are on call 24 hours a day, seven days a week, 365 days a year.

A full-service medical practice, Touring Health can provide lab work, IV hydration therapy, consults with doctors, Telehealth appointments with doctors, and same day prescription treatments. They also provide referrals to specialists, and PCR testing for Covid, RSV, Flu, and Strep with same day results. Touring Health’s VIP services are designed to support each client’s individual goals, whether it is optimal physical strength and performance, clearing brain fog, recovering from a medical procedure, treatment of an acute illness, or just wanting to look and feel their absolute best.

“Touring Health is a game changer for the touring industry. Having used them on many of my tours since 2021 with great success, I see the benefits that they can offer any tour. With Touring Health on board, the health and well-being of my artists and production team are completely covered.” – Marty Hom, Tour Director

“Touring Health has been an amazing and reliable asset while touring over the last year for myself. I can rely on their services from basic health needs such as B-12 shots and prescriptions for the average cold, to Covid testing and IVs. It’s is another great layer to add to any touring team to help keep everyone healthy and on the move.” – Tony Marino, Tour Manager

The mission of Touring Health is to provide real-time medical solutions to save productions and tours time and money. They are providing one-on-one care and comprehensive wellness services from rehearsals to the final encore, coast-to-coast and beyond. Visit TouringHealth.com for more information and to explore booking their services for your next gig. Service, wellness, and safety isn’t just their motto; it’s the principle Touring Health professionals live by. Shouldn’t you?

Media Contacts:


Full Name
Judith Moose
Company
JM Media Group
Phone Number
7023543685
Website
http://www.jm-media-group.com
Email

Compose your email to Judith Moose at JM Media Group.


  Spam Protection

The Pediatric Orthopedic Center Launches Comprehensive Center for the Female Athlete that Extends Beyond Orthopedics

Comprehensive Center for the Female Athlete in Morris County NJ

USA, February 3, 2024 (Global News Distribution) -

Today on National Women’s Physician Day, The Pediatric Orthopedic Center (TPOC) has relaunched their Center for the Female Athlete to extend beyond orthopedics. Their dedicated team, comprised of 50% female orthopedic surgeons, is committed to providing comprehensive care for the specialized needs and injuries of young female athletes. Having built trusted relationships with some of the best providers in the area, the Center for the Female Athlete now offers its patients a list of recommended specialists including but not limited to psychologists, nutritionists, adolescent medicine specialists, and endocrinologists, to ensure your daughters receive the best possible care.

Comprised of four female pediatric orthopedic surgeons, Samara Friedman, MD, FAAOS; Anna Katsman, MD; Sarah Stelma, MD; and Alexandra D’Agostini, MD; as well as a nationally-certified orthopedic physician assistant, Jaime Morley, MS, PA-C, the Center of Excellence for the Female Athlete focuses on the unique medical conditions and injuries due to trauma or overuse of young female patients. While the national average for female orthopedic surgeons is only 6%, The Pediatric Orthopedic Center offers female athlete the choice between 4 female and 4 male orthopedic surgeons, in addition to a pediatric foot and ankle specialist, and orthopedic physician assistant.

According to Dr. Samara Friedman, the leading physician at the Center of Excellence for the Female Athlete, “Our keen focus is on the specialized needs and injuries of female athletes, including their unique physical and medical conditions, as well as psychological pressures. The Center of Excellence for the Female Athlete offers a safe space for female athletes to discuss their injuries, concerns and needs with highly-credentialled, compassionate providers. As athletes, sports team coaches, and physicians that have experience working with professional sports teams as well, we bring deep expertise to this specialized area of practice.”

Girls’ participation in high school sports has grown from less than 300,000 in the early 1970s to almost 3.5 million during the 2018-19 school year. In fact, female adolescents now make up almost 43% of high school athletes, according to the National Federation of State High School Associations. Due to their unique anatomical differences, female athletes are at an increased risk of sustaining ACL tears and overuse injuries compared to their male counterparts, for example, and are especially susceptible to injury during periods of rapid growth.

TPOC offers cutting-edge diagnostic tools, including the highly-accurate, low-dose EOS Imaging system, the only one of its kind in northern N.J., as well as the latest treatment options, such as the BEAR (bridge-enhanced anterior cruciate ligament repair) technique, to treat a myriad of injuries and orthopedic conditions including:

• Knee injuries: ACL tears, meniscus tears, and knee cap dislocations
• Shoulder and elbow injuries: sprains, tears, dislocation, and instability
• Hip injuries: hip dysplasia, sprains, strains, impingement, and labral tears
• Foot and ankle injuries, including ankle sprains
• Scoliosis and other spine deformities
• Fractures, ligament and muscle/tendon injuries
• Overuse and growth plate injuries, including osteochondritis dissecans

About The Pediatric Orthopedic Center
The Pediatric Orthopedic Center is the largest pediatric orthopedic practice in New Jersey and among the largest private pediatric orthopedic practices in the United Sates, with three offices located in Cedar Knolls, Wayne, J and Springfield. It is the only pediatric orthopedic practice in NJ that provides an urgent care center with evening and Saturday hours. The practice specializes in youth and adolescent sports trauma, spine deformities, hip disorders, and foot and ankle surgery. It features seven board certified and/or fellowship-trained pediatric orthopedists, a pediatric specialized foot and ankle specialist and a nationally certified orthopedic physician assistant. For more information, visit: pediatricorthopedics.com.

Media Contacts:


Full Name
Allison Tully
Company
The Pediatric Orthopedic Center
Phone Number
+1 9739190871
Website
Email

Compose your email to Allison Tully at The Pediatric Orthopedic Center.


  Spam Protection

2022 Health Care Quality and Management Certification (HCQM®) Exam Application Deadline Extended to June 30

June 6, 2022 (Global News Distribution) -

The American Board of Quality Assurance and Utilization Review Physicians (ABQAURP) Provides a Certification to Validate and Differentiate Today’s Health Care Quality and Safety Professionals

The importance of health care quality and patient safety continues to be at the forefront of providing medical care. It is essential that health care providers and administrators demonstrate their expertise and commitment to health care quality and safety. In addition to concerns about patient safety, inappropriate services, and unnecessary readmissions, the rising costs of health care and its impact on families and business all solidify the need for Health Care Quality and Management (HCQM) Certification.

Realizing what a hectic time it is for health care professionals around the world, ABQAURP strives to make certification accessible, therefore the HCQM Application deadline has been extended to June 30, 2022. ABQAURP humbly thanks you for your tireless efforts during this unprecedented time. The 2022 HCQM Exam will be administered from June 1 through September 30, 2022.

ABQAURP continues to work with Prometric on test development and delivery for its HCQM Certification Exam. The exam is provided through Prometric’s global test center network and remotely via ProProctor™. The ProProctor remote testing platform allows candidates to test anywhere, at any time.

Dr. Nick Paslidis, ABQAURP Chairman of the Board, states, “Physicians, nurses, and other health care professionals throughout the world are able to sit for ABQAURP’s HCQM Certification Examination. We encourage health care professionals worldwide to be recognized for their commitment to value-driven, quality care by earning the CHCQM® (Certified in Health Care Quality Management) credential.”

Health care leaders can enhance their HCQM credential with additional sub-specialty certifications in the following categories:

  • Case Management
  • Managed Care
  • Patient Safety / Risk Management
  • Physician Advisor (Physicians Only)
  • Transitions of Care
  • Workers’ Compensation

The HCQM Examination and Physician Advisor Sub-Specialty are endorsed by the American College of Physician Advisors (ACPA). HCQM Certification and the physician advisor sub-specialty align with ACPA’s mission to promote and expand the prominent role of the Physician Advisor in today’s rapidly changing health care environment through education, certification, mentorship, and collaboration; as well as ABQAURP’s mission to improve the overall quality of health care provided to the public.

Prepare now for the 2022 HCQM Examination! ABQAURP is accepting applications through June 30th for the HCQM Test Window that will be open from June 1 through September 30, 2022.

Visit the ABQAURP website at: http://www.abqaurp.org/Certification or call (800) 998-6030 to learn how HCQM Certification can validate your experience and set you apart from the rest!

About ABQAURP
Celebrating 45 years of excellence in Health Care Quality Management and Patient Safety, ABQAURP is a premier professional association providing Health Care Quality and Management (HCQM) certification, ACCME-accredited continuing medical education, and membership to health care professionals worldwide. Learn more at: http://www.abqaurp.org.

Contact Author

BARBARA THOMAS

ABQAURP
7275690190

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Lexaria Grants License to Valcon Medical for the European Market

June 2, 2022 (Global News Distribution) -

  • Contract Manufacturing Organization first in Europe to License DehydraTECH
  • Lexaria will receive milestone fees and royalty payments from product sales

Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce the awarding of a European and United Kingdom (“UK”) DehydraTECH license for medical cannabis applications from Lexaria Pharmaceutical Corp. to Valcon Medical A/S (“Valcon”).

Valcon Medical is a European contract manufacturing organization (“CMO”), specialized in the manufacturing of medical cannabis extracts for the European Union (“EU”) and the UK. Valcon is GMP certified and licensed under the Danish medical cannabis program to manufacture cannabis products that require physician-patient consultation.

Valcon products will span non-registered medical products through magistral programs, country-level market-authorized medical cannabis products through pilot programs, and country and/or EU Commission registered medical cannabis products. These products include bulk powders or solid oral dosage forms including, but not limited to, powder-filled capsules, compressed tablets, pills, oral melts, and topical creams and lotions with or without patch integration.

The non-exclusive license includes a combination of defined milestone fees payable to Lexaria upon completion of batch validation and marketing authorization application approvals for the first DehydraTECH-enabled products completed by Valcon for each of several product categories it shall pursue, together with defined royalties payable to Lexaria on revenues generated from Valcon’s product sales.

“We are very excited to have licensed Lexaria’s DehydraTECH technology for what we expect will be rapid growth across the European markets,” said Pete Patterson, CEO of Valcon Medical A/S. “As Valcon continues to build out its manufacturing capabilities we are developing new IP and partnering with industry leaders. Lexaria has developed and patented an incredible technology which will benefit medical cannabis patients with enhanced bioavailability with a quicker effect onset. Backed by substantial clinical efficacy studies, Valcon will bridge the extensive work that Lexaria has done in the US, over to Europe.”

Lexaria notes the potential for growth in utilization of DehydraTECH across these European markets given the advanced technical capabilities of Valcon, and their business focus on providing CMO services to a wide spectrum of companies active in the EU.

About Valcon Medical A/S

Founded in 2018, Valcon Medical is the most advanced medical cannabis manufacturer in its field in Europe and leads the cannabis industry in manufacturing capacity and production of the highest quality full spectrum extracts and API cannabinoid isolates. Valcon Medical is supported by a shareholder group comprised of some of the leading cannabis investment funds in the world, including Altitude Capital, Artemis Growth Partners, Enexis AB, Greenfield Global Opportunities, and Nimb Capital.

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp.’s patented drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered antiviral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, please visit www.lexariabioscience.com.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the company relating the Company’s ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements. As such, you should not place undue reliance on these forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company’s ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company’s public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law.

INVESTOR CONTACT:
George Jurcic – Head of Investor Relations
ir@lexariabioscience.com
Phone: 250-765-6424, ext 202

SOURCE: Lexaria Bioscience Corp.

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Data Center Leader Volico Selects Healthcare Technology Veteran

May 25, 2022 (Global News Distribution) -

Grant MGaugh joins Volico data centers as new healthcare business development executive

Volico continues to Expand its Industry-Leading Sales Team

May 02, 2022 – Volico is a leading data center solutions provider to healthcare, is pleased to announce that Grant McGaugh, based in Deerfield Beach Fl, has joined the company as Healthcare Business Development Executive. Mr. McGaugh is responsible for demonstrating the breadth of services and solutions available to Healthcare IT teams through professional consulting with a keen focus on improving the patient experience for the Healthcare Industry.

As an IT Sales Professional with expertise in marketing and sales, Mr. McGaugh has over 25 years of consulting experience, with a focus on prospecting and lead generation, effective research and problem solving, and overall development of meaningful business relationships.

“Grant’s innate ability to connect services to client needs brings a distinct advantage to the Volico Data Center Sales team,” said Gadi Hus, Director of Operations. “His knowledge and experience complement well the individual and collective strengths of our local team.” Skilled in the execution of design and implementation strategy, Mr. McGaugh has a broad background in leveraging colocation, dedicated servers, cloud computing, Enterprise Hosting, Storage and Backup services with leading IT engineers and professional certifications, as well as managing the end to end consulting engagement and service delivery process from cradle to grave. Grant delivers highly competitive service offerings and portfolios for his clients.

“It’s refreshing to work with a company that has created a culture where clients are genuinely paramount to the organization and quality customer service is actually a ‘habit,'” commented McGaugh. “At Volico Data Centers, employee and client expectations are always met with an impressive sense of urgency and extraordinary execution.”

Mr. McGaugh has worked at the expert and executive level for multiple Fortune 500 organizations such as Connection, Zones, Inc., Century Link (aka Lumen), and Avaya. He has received numerous awards and special recognition, such as the 2020 nomination for African American Achievers 2020 by JM Family Enterprises, 2019 award for Healthcare Leadership by Legacy Magazine, the 2018 Gold Sales Achiever, Gold Award Honors, and the President’s Club.

About Volico Data Centers
Founded in 2000, Volico is a HIPAA, SSAE, SOC, and NIST Compliant Enterprise-Class Data Center solutions provider, specializing in colocation, enterprise dedicated server hosting, disaster recovery, business continuity, backup services, private cloud computing, public cloud computing, and CinC (Cloud in Cloud) IAAS computing.

The company currently operates multiple data centers servicing clients in Miami-Dade County, Broward County, and West-Palm Beach Counties of sunny South Florida. Volico’s data center provides the highest level of redundancy and flexibility. The South Florida colocation facility contains: an unprecedented 2N+X redundant UPS Smart-Grid infrastructure and a 2N+X redundant generator Smart-Grid Paralleling Technology. Our Healthcare Healthcare Solutions includes the following:

✓ Tier IV Carrier Neutral Data Center.
✓ Managed Services and Infrastructure.
✓ Private and Hybrid Cloud Solutions.

Volico helps healthcare organizations and businesses who need to run back-office applications without the expensive cost of handling a self-hosted environment. Volico’s technology solutions for healthcare are designed to minimize costs while improving and upgrading patient experience.

Volico can craft a fully managed hosting solution to help organizations meet HIPAA compliance requirements. Commitment to regulations and to health care industry customers, Volico provides highly secure and scalable HIPAA compliant hosting solutions to fit all ranges of organizational sizes from small to big.

Please contact Grant McGaugh directly for more information at gmcgaugh@volico.com or call at (754) 227-4835.

Grant McGaugh | Book a MeetingBusiness Development Executive | Data Center Solutions
Volico Data Centers
P: 305-735-8098 Ext. 708 | D: 754-227-4835
A: 500 Green Rd. Deerfield, FL 33064
W: Volico.com | E: gmcgaugh@volico.com

Contact
Grant McGaugh

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

US Veterans and Injured Workers Find Injury Solution With sam® Sustained Acoustic Medicine Treatment

May 11, 2022 (Global News Distribution) -

Innovative medical technologies like the sam® device promote soft tissue healing

Sustained acoustic medicine, or sam®, is a non-invasive ultrasound device from ZetrOZ Systems used to treat soft tissue injuries and arthritis. The U.S. Federal Drug Administration cleared sam® for clinical use in 2013, but many health care providers are just now discovering the many benefits it provides to treatment and recovery efforts.

The sam® pain relief device has helped thousands of patients, including U.S. Veterans and Active Duty Members, regain mobility and reduce pain from common overuse injuries and osteoarthritis. “Sam has been a wonderful medical device to represent in our region since the benefit to patients is tremendous, the product is made in the USA, and the clinical outcomes are clear,” says Mr. Harmon, President of a well-established & long-time distributor for ZetrOZ Systems. “We have no other medical device that can help patients heal faster and reduce the need for surgery and opioids.”

ZetrOZ is driven by innovation, and the sam® pain relief technology is clinically proven to augment the body’s natural ability to heal. “We have been offering sustained acoustic medicine (sam®) since 2016. We have helped countless patients restore function and reduce narcotic and opioid use thanks to sam®. It is truly unique,” says Mr. Harmon.

Healthcare systems like the U.S. Veterans Administration have also adopted sustained acoustic medicine to help patients dealing with soft tissue injury or chronic pain. For veterans of the United States military, as well as senior citizens, having access to the sam® device is a key part of their recovery. A nurse we will refer to as “Lori” in a very busy and influential VA pain management department uses the sam® device in place of opioids whenever possible. “The sam® device is the only thing in pain management that makes me feel like I am doing a great job for my patients,” Lori says. “It makes my patients feel much better.”

The sam® device can be used on any joint — even a patient’s hand — and reduces the risk of long-term NSAID use. “We have almost no issues with any of our patients using the device. We have treated younger patients and patients that are 85 years of age,” Lori says, noting the clinical efficiency of the device for both men and women. For older patients, the technology can seem daunting, so it is important to train patients on how to apply, charge, clean, and reuse the device before they receive treatment.

Lori instructs patients to never apply sustained acoustic medicine to the carotid arteries or their genitalia. Sometimes the area must be shaved for better coupling, but this step is not necessary for most patients. She also recommends applying sam® with a topical diclofenac just beyond the margins of pain. Once the diclofenac dries, the device can be placed over the painful spot. She instructs patients to follow this same process for four hours per day. “Our patients have excellent results on all types of arthritis of the knee and hand,” says Lori. “We also use the device a lot on muscle spasms and back injuries.”

A recent study determined that sam® reduces pain even in patients who have not responded to other types of physical therapy. Lori hopes that future research will focus on the clinical outcomes of using sam®, especially with challenging conditions like chronic regional pain syndrome and neuropathy. While affirmation from this research is important, George Lewis, President and CEO of ZetrOz Systems, as well as the inventor of sam®, notes that the clinical healing and pain relief the device provides to patients is what matters most.

Visit samrecover.com or zetrozsystems.com to learn more about this device and how it can support clinical outcomes within your organization or medical practice.

About ZetrOZ Systems
ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produced UltrOZ®, sam®Sport and sam®Pro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.com and samrecover.com.

Media Contact:

Buse Kayar
buse@newswire.com
www.Newswire.com

Source: ZetrOZ Systems

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Cummings Graduate Institute Joins Second National ‘Mental Health Action Day’ to Drive Culture of Mental Health from Aware

May 10, 2022 (Global News Distribution) -

Setting the theme of ‘Connection,’ Cummings Graduate Institute and more than 1500 companies and organizations will drive calls to action to address the surge of loneliness and isolation felt by millions as a result of the pandemic

Cummings Graduate Institute for Behavioral Health Studies (CGI) announces today its participation in the second-annual Mental Health Action Day held on Thursday, May 19 with more than 1,400 other leading companies, brands, nonprofits and cultural leaders globally during Mental Health Awareness Month.

As the global conversation around mental health continues – including the White House’s new unity agenda strategy to address mental health in the United States – finding effective resources and knowing how to get help remains a challenge. Convened by MTV Entertainment Group, Mental Health Action Day was created with an open-source model that has effectively united and galvanized brands, organizational leaders, and cultural leaders to seamlessly integrate the message and spirit into their existing branding and voice.

This year’s Mental Health Action Day theme, planned in partnership with TaskForce, is Connection as people of all ages continue to seek out ways to cope with loneliness stemming from the pandemic and turn to peer counseling to support their emotional wellbeing when struggling with isolation. We will encourage people to take their first steps towards mental health action — whether for themselves, for their loved ones or to advocate for systemic changes through a wide range of  tools. Additionally, this year MTV has piloted a new partnership model, Mental Health Action Champions, that empowers interested partners and provides them with the freedom to innovate, manage, and customize a sector-specific strategy powered by Mental Health Action Day.

“We are thrilled to be an official partner for MTV’s Second Annual Mental Health Action Day. The pandemic has shined a light on the mental health challenges Americans face each day,” said Melissa McGurgan of Cummings Graduate Institute for Behavioral Health Studies. “According to the World Health Organization, during the first year of the COVID-19 pandemic, the global prevalence of depression and anxiety increased by 25%. It is inspiring to see a variety of organizations together to raise awareness on this issue and to help to take action in our communities to support one another.”

“The last two years have brought to light mental health challenges and made it easier to talk about them – but there is still so much work to do to help people take actions to address them,” said Erika Soto Lamb, Vice President of Social Impact Strategy at MTV Entertainment Group. “That’s why the second Mental Health Action Day will focus on connection by providing leaders with resources to encourage and empower people to take action and those struggling with mental health and isolation with the tools they need to improve their emotional wellbeing.”

Cummings Graduate Institute for Behavioral Health Studies and all Mental Health Action Day Partners will encourage people to take their first steps towards mental health action — whether for themselves, for their loved ones or to advocate for systemic changes. No cost resources and tools, such as an employer toolkit and platforms for hosting and organizing events, are available for organizations and groups to help support their audiences through a myriad of ways – from starting a meditation practice to learning how to support a friend to advocating for change.

Additional participants and more information about how each partner will activate on May 19 will be forthcoming. More on Mental Health Action Day and a current list of partners can be found at www.MentalHealthActionDay.org

About Mental Health Action Day
Mental Health Action Day is an open-source movement of brands, organizations and cultural leaders to drive culture from mental health awareness to mental health action. The second Mental Health Action Day will take place on May 19, 2022 with a mission to encourage and empower people to take their first steps towards mental health action — whether for themselves, for their loved ones or to advocate for systemic changes, because mental health is health. Learn more at www.MentalHealthActionDay.org

About Cummings Graduate Institute for Behavioral Health Studies
Cummings Graduate Institute for Behavioral Health Studies, a private, nonprofit, DEAC accredited institution, offers education and training in integrated behavioral healthcare through a virtual online campus. To learn more about Cummings Graduate Institute for Behavioral Health Studies, visit https://cgi.edu/.

Contact
J. Carro
Marketing & PR

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Everest Rehabilitation Hospitals Announces Medical Patient Transportation Services

April 26, 2022 (Global News Distribution) -

Everest Rehabilitation Hospitals announces medical transportation services for its’ patients; something that is very unique for Inpatient Physical Rehabilitation Hospitals.

Everest Rehabilitation Hospitals, LLC announces the launch of their medical transportation services at all Everest Rehabilitation Hospital locations. This exciting news comes as an additional solution to providing outstanding quality medical service to Everest patients at the start of the healing process. “At Everest, we pride ourselves on providing the best care possible to all our patients. We saw a huge gap in quality with outsourced medical transportation services. Bringing controlled in-house medical transportation services to our referring hospitals and our patients helps ensure they receive the highest quality care as soon as they are in our hands.” Jay Quintana, Everest Rehabilitation’s CEO said. The private medical transportation vehicles are exclusively used for Everest patients.

Everest Rehabilitation Hospitals has acquired luxury state-of-the-art transportation vehicles and customized them to benefit their patients. The vehicles provide a smooth, private and safe ride with top-of-the-line comfort and have been customized to be rear entry accessible for patients in wheelchairs. Each van is branded with Everest’s signature blue logo and mountains; everyone will know when they are coming and going.

Patients and families can expect five-star service from all Everest drivers just as they have come to expect from Everest Rehabilitation Hospital staff. Professional drivers will be available to assist all passengers during their transportation to and from Everest locations. “We are thrilled to service the community with professional drivers for all patients!” said Jay Quintana. “This is another way we will ease the transition to our Physical Rehabilitation Hospital during what can be a very stressful time for patients and their families.”

Everest Rehabilitation Hospitals include a comprehensive and interdisciplinary physician-led experienced team of rehabilitation therapists focused on increasing patient strength and endurance and improving quality of life in a modern, state of the art setting.

About Everest Rehabilitation Hospitals, LLC

Everest Rehabilitation Hospitals LLC, based in Dallas, Texas, is a multispecialty acute care physical rehabilitation hospital company focused on providing high quality, physical rehabilitation care. Everest is passionate about patient care; striving to create healing and nurturing environments for all patients that not only meet their medical needs but address their emotional and social needs as well. Patients are guided through the necessary steps to reclaim daily life, recover function, and return to an optimal quality of life by combining the latest treatments, technologies, and research with a unique interdisciplinary team approach involving the patient and family from day one. Everest provides the highest level of care available to patients with disabilities caused by injuries or illnesses, or from traumatic accidents.

http://www.everestrehab.com

Jay Quintana, CEO/ Co-Founder
Jquintana(at)everestrehab.com

469-713-1145

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

May is Ultraviolet Awareness (UV) Month at Prevent Blindness, Designed to Educate the Public on the Best Ways to Keep Eyes Safe from UV Damage

April 25, 2022 (Global News Distribution) -

Prevent Blindness provides free, dedicated resources to encourage proper eye protection from negative effects of UV

As the warmer weather begins to encourage more outdoor activities, Prevent Blindness, the nation’s oldest eye health and safety organization, has declared May as Ultraviolet (UV) Awareness Month. The nonprofit group is seeking to educate the public on the negative effects of UV exposure to the eyes and vision, offering a dedicated webpage, PreventBlindness.org/sun-and-vision, downloadable fact sheets and shareable social media infographics.

There are two types of UV rays: UV-A and UV-B. Over time, the effects of UV rays may help cause a number of eye problems. UV-A rays may affect central vision. They can damage the macula, a part of the retina at the back of the eye. The front part of the eye (the cornea and the lens) absorbs most UV-B rays, but these rays may cause even more damage to the eyes than UV-A rays.

According to the Wilmer Eye Institute and Johns Hopkins Medicine, corneal damage, cataracts and macular degeneration are all possible chronic effects from UV exposure and can ultimately lead to decreased vision. Additionally, UV light is associated with skin cancers including squamous cell carcinomas, basal cell carcinomas, and cutaneous melanoma. Squamous cell carcinoma can occur not just on the skin, but on the conjunctiva and invade the cornea and inside of the eye, in some cases necessitating removal of the entire eye.

The Hidden Dangers of UV: Keeping Your Eyes Safe report from The Vision Council lists factors that put people’s eyes at greater risk of damage from UV exposure, including:

  •     Geography- In the United States, southern communities tend to receive more intense solar rays than northern ones. Elevation can also be a factor, since the thinner atmosphere at higher altitudes cannot absorb as much radiation. At the beach, sand or water can reflect up to 25% of UV; on a snow-covered surface, as much as 80% of UV may be reflected – adding to the initial exposure.
  •     Age- Children receive three times the annual sun exposure of adults, and research has shown that their young eyes are especially susceptible to UV-related harm. Unlike the mature lens of an adult eye, a child’s lens cannot filter out UV rays and so more radiation reaches the retina. At the same time, decades of sun exposure make older people’s eyes much more prone to visual problems and disease.
  •     Eye color- The color of the eye appears to play a role, with some studies suggesting that blue eyes are at more risk for UV damage than brown eyes. The protective pigment melanin may be the key detail – blue irises have less of it – and a higher incidence of age-related macular degeneration may be one consequence.

Prevent Blindness strongly recommends wearing UV-blocking sunglasses as well as a brimmed hat to provide the best protection against UV rays. Sunglasses should:

  •     reduce glare
  •     filter out 99-100% of UV rays
  •     be comfortable to wear
  •     not distort colors

“Spending time outdoors offers many health benefits. We encourage adults and children to wear the proper UV protection for their eyes to keep them safe and healthy today, and in the years to come,” said Jeff Todd, president and CEO of Prevent Blindness.

For more information on UV eye protection, please visit the Prevent Blindness dedicated webpage at PreventBlindness.org/sun-and-vision, or call (800) 331-2020.

About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at preventblindness.org, and follow us on Facebook, Twitter, Instagram and LinkedIn.

Contact Author

SARAH HECKER

Prevent Blindness
312.363.6035

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Collaborations Pharmaceuticals, Inc. Awarded A Matching Grant from One North Carolina Small Business Program

April 12, 2022 (Global News Distribution) -

The North Carolina Department of Commerce has awarded a matching award totaling $75,000 to Collaborations Pharmaceuticals, Inc. to support cutting edge science.

“Collaborations Pharmaceuticals, Inc. (CPI) are honored to receive a matching grant award under the FY 21-22 One North Carolina SBIR/STTR Matching Funds Program Solicitation. This was awarded to match our recent NIEHS SBIR to develop software and machine learning models for acetylcholinesterase (AChE) inhibition prediction. These models will then be used to identify potential molecules that bind to AChE in order to predict potential for pesticide poisoning across species and potential for environmental contamination. Organophosphorus pesticides are one of the most common causes of poisoning worldwide estimated to cause nearly 3 million poisonings per year resulting in three hundred thousand deaths (8000 in the US) and our hope is to identify additional molecules that may impact our environment and human health” said Sean Ekins, CEO, CPI.

This funded project will build upon our Assay Central® software developed by CPI to enable the generation of machine learning models using data from public or private sources. This software is being licensed to large pharmaceutical and consumer product companies for a range of applications. Our research on artificial intelligence has direct health and defense applications.

Disclaimer
“Research reported in this publication was supported by the National Institute Of Environmental Health Sciences of the National Institutes of Health under Award Number 1R43ES033855-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

About Collaborations Pharmaceuticals, Inc.
Collaborations Pharmaceuticals, Inc.® has developed software for data curation and machine learning called Assay Central® (www.assaycentral.org) as well as curated model bundles in MegaTox®, MegaTrans® and MegaPredict®. Most recently we have developed MegaSyn and UV-adVISor. CPI performs research and development on innovative therapeutics for multiple rare and neglected diseases and is located in laboratories in the NC State Incubator at Centennial campus. We have considerable experience with preclinical and computational approaches to drug discovery and toxicity prediction. For more information, please visit http://www.collaborationspharma.com/

Sean Ekins
Collaborations Pharmaceuticals, Inc.
+1 215-687-1320

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection